The FDA has approved a new omega-3 supplement (brand name, Epanova) to 
treat adults with severe hypertriglyceridemia, defined as triglyceride 
levels 500 mg/dL or higher.

In its announcement, the manufacturer said that Epanova is the first 
omega-3 formulation approved by the FDA in free fatty acid form. It 
will be available in 1-g capsules and has been approved for 2-g and 4-
g dosages, which can be taken with or without food.

There are currently two other prescription formulations of omega-3 
supplements on the market: Lovaza and Vascepa. All three are approved 
only for the treatment of severe hypertriglyceridemia, though studies 
of expanded indications are underway.

By Larry Husten